| Net income | 494M |
| Depreciation | 940M |
| Amortization | |
| Loss from equity investments, net of cash distributions | |
| Deferred income taxes | 173M |
| Equity-based compensation expense | 41M |
| Excess tax benefit from equity-based compensation | -68M |
| Receivables | 65M |
| Accounts payable and other liabilities | 94M |
| Other changes | -165M |
| Cash provided by operating activities | |
| Acquisitions and investments, net of cash acquired and distributions received | |
| Capital expenditures | -1.32B |
| Other investing activities | 4M |
| Cash used by investing activities | |
| Borrowings (repayments), net | 0 |
| Borrowings | |
| Repayments | |
| Debt issuance costs | |
| Proceeds from exercise of stock options | 58M |
| Excess tax benefit from equity-based compensation | 68M |
| Dividends paid | -217M |
| Repurchases of common stock | |
| Other financing activities | -1M |
| Cash used by financing activities | |
| Increase (decrease) in cash and equivalents | 127M |
| Cash and equivalents at beginning of period | 1.17B |
| Cash and equivalents at end of period | 1.3B |